Treace Medical Concepts, Inc. TMCI Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 79.8%-0.6pp | 80.4%-0.8pp | 81.2%-0.8pp | 82%-0.1pp | |
| Operating margin | -25.5%+1.1pp | -26.6%+0.9pp | -27.5%-2.9pp | -24.6%-7.1pp | |
| Net margin | -27.7%-1.1pp | -26.6%-0.2pp | -26.5%+3.7pp | -30.2%-8.4pp | |
| EBITDA margin | -20.5%+2.1pp | -22.6%+2.0pp | -24.6%-1.5pp | -23.1%-6.4pp | |
| Free cash flow margin | -13.9%+9.4pp | -23.3%+1.3pp | -24.6%+7.5pp | -32.1%-11.0pp | |
| Returns | |||||
| Return on equity | -58.9%-14.5pp | -44.4%+5.5pp | -49.9%+5.8pp | -55.7%-12.0pp | |
| Return on assets | -28.9%-5.2pp | -23.8%+0.3pp | -24.1%+4.5pp | -28.6%-6.1pp | |
| Return on invested capital | -33.9%-3.5pp | -30.4%+3.3pp | -33.7%+21.5pp | -55.2%+13.8pp | |
| Efficiency | |||||
| Asset turnover | 1×+0.2× | 0.9×0.0× | 0.9×0.0× | 0.9×-0.1× | |
| Inventory turnover | 1.1×-0.1× | 1.2×-0.2× | 1.4×-0.3× | 1.7×-0.1× | |
| Liquidity | |||||
| Current ratio | 4.3×-0.3× | 4.6×+0.2× | 4.4×0.0× | 4.4×-3.2× | |
| Quick ratio | 3.1×-0.4× | 3.5×-0.3× | 3.8×0.0× | 3.8×-3.2× | |
| Cash ratio | 0.3×0.0× | 0.3×0.0× | 0.3×-0.4× | 0.6×-5.2× | |
| Leverage | |||||
| Debt-to-equity | 0.8×+0.2× | 0.6×+0.1× | 0.5×-0.6× | 1.1×+0.8× | |
| Debt-to-assets | 0.4×+0.1× | 0.3×0.0× | 0.3×-0.2× | 0.4×+0.2× | |
| Interest coverage | -10.2×+0.4× | -10.6×-0.6× | -10×-2.0× | -7.9×-3.9× | |
| Per Share | |||||
| Book value per share | $1.38-24.1% | $1.82-19.8% | $2.27+107% | $1.10-43.0% | |
| Valuation | |||||
| Market capitalization | $258.19M-26.6% | $463.49M-41.1% | $786.67M-38.4% | $1.28B+25.0% | |
| Enterprise value | $320.25M-22.6% | $521.79M-38.2% | $843.99M-36.4% | $1.33B+40.3% | |
| Price / sales | 1.3×-0.4× | 2.2×-2.0× | 4.2×-4.8× | 9×-1.8× | |
| Price / book | 3.3×-0.3× | 4.1×-1.6× | 5.7×-15.4× | 21.1×+10.1× | |
| EV / sales | 1.5×-0.4× | 2.5×-2.0× | 4.5×-4.8× | 9.4×-0.7× | |
| Free cash flow yield | -10.1%-1.8pp | -10.5%-4.7pp | -5.9%-2.3pp | -3.6%-1.6pp | |
| Earnings yield | -23.6%-9.7pp | -12%-5.7pp | -6.3%-2.9pp | -3.4%-1.3pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Treace Medical Concepts, Inc.'s profit margins?
- Treace Medical Concepts, Inc. (TMCI) runs a 79.7% gross margin and a -26.9% operating margin, with a -29.4% net margin.
- Where do Treace Medical Concepts, Inc.'s ratios come from?
- Every ratio is computed from Treace Medical Concepts, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
